|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3319993 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16739079.8 |
| Date of filing the European patent application | 2016-07-08 | |
| (97) | Date of publication of the European application | 2018-05-16 |
| (45) | Date of publication and mention of the grant of the patent | 2020-01-15 |
| (46) | Date of publication of the claims translation | 2020-05-11 |
| (86) | Number | PCT/EP2016/066353 |
| Date | 2016-07-08 |
| (87) | Number | WO 2017/009258 |
| Date | 2017-01-19 |
| (30) | Number | Date | Country code |
| PCT/EP2015/0659 | 2015-07-10 | WO | |
| 201662278283 P | 2016-01-13 | US |
| (72) |
BOSHUIZEN, Julia, NL
JACOBSEN, Kirstine, DK
BREIJ, Esther, NL
KOOPMAN, Louise, NL
SATIJN, David, NL
VAN DEN BRINK, Edward, NL
VERZIJL, Dennis, NL
DE JONG, Rob, NL
VAN DIJKHUIZEN RADERSMA, Riemke, NL
PEEPER, Daniel, NL
DITZEL, Henrik J rn, DK
PARREN, Paul, NL
|
| (73) |
Genmab A/S,
Carl Jacobsens Vej 30, 2500 Valby,
DK
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | AXL specifiniai antikūno-vaistokonjugatai, skirti vėžiui gydyti |
| AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT |
| Payment date | Validity (years) | Amount | |
| 2025-06-04 | 10 | 231.00 EUR |
| 2026-07-08 |